Here’s whether Thermo Fisher Scientific, Inc. (TMO) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.02% over 10 days); strong 1-year return of +19.6%; 3-month momentum positive (+21.0%). Concerns: RSI 72 — overbought, elevated pullback risk. Currently 11.8% off its 52-week high. Score: +5/7.
TMO is in a confirmed uptrend, trading above both its 50-day ($491.99) and 200-day ($529.70) moving averages. With an RSI of 72.4, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +19.6% compares to +20.4% for SPY (trailed the market by 0.7%).
$10,000 invested 1 year ago→ $11,963 today
vs. S&P 500 (SPY) — same period trailed market by 0.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($529.70)
✓Above 50-day MA ($491.99)
!RSI(14) neutral zone (30–70) — currently 72.4
✓Positive return (+19.6%)
!Within 10% of period high (−11.8%)
Period Range $568.26
$435.27$643.99
RSI (14) 72.4
0 · OversoldOverbought · 100
Key Metrics
Price$568.26
Period Return+19.6%
Period High$643.99
Period Low$435.27
Drawdown−11.8%
MA-50$491.99
MA-200$529.70
RSI (14)72.4
Avg Volume (30d)2.3M
vs. SPYbeat by 3.2%
Return Rank#477 of 1252
Trend Signals
Price is above the 200-day moving average ($529.70)
Price is above the 50-day moving average ($491.99)